Category Archives: Omeros

Washington companies win $34 million in Therapeutic Discovery Project Grants

Washington life sciences companies won more than $34 million in grants through the U.S. Internal Revenue Service under the Qualifying Therapeutic Discovery Project Program which was created by the Affordable Care Act. The grant covers up to 50 percent of … Continue reading

Posted in EKOS, Funding, Healionics, Insilicos, IsoRay, Life_Sciences, NanoString_Technologies, Omeros, Pathway_Medical_Technologies, Stratos_Genomics, VisionGate | Leave a comment

Life Sciences Discovery Fund to start new initiative with Omeros proceeds

Washington’s Life Sciences Discovery Fund (LSDF) announced “a $5 million grant to Seattle-based Omeros Corporation to discover, develop, and commercialize new drugs to treat a variety of major diseases. With successful generation of proceeds through partnering and the sales of … Continue reading

Posted in Company_and_Client_News, Funding, Life_Sciences, Life_Sciences_Discovery_Fund, Omeros | Leave a comment

Omeros gains $20M from Vulcan and $5M from Life Sciences Discovery Fund

Omeros Corporation, a Seattle-based clinical-stage biopharmaceutical company, announced “that it has received $20 million from Vulcan Capital (Vulcan) and a grant award for $5 million from Washington State’s Life Sciences Discovery Fund (LSDF) to support the advancement of the Company’s … Continue reading

Posted in Company_and_Client_News, Funding, Life_Sciences, Life_Sciences_Discovery_Fund, Omeros | Leave a comment

Omeros addiction program study wins $3.6M federal grant

Omeros Corporation, a Seattle-based clinical-stage biopharmaceutical company, announced that the National Institute on Drug Abuse (part of the NIH) has provided an additional grant — $3.6 million over four years — to fund clinical studies for the company’s addiction program. … Continue reading

Posted in Company_and_Client_News, Funding, Life_Sciences, Omeros | Leave a comment

Omeros receives support for clinical study from National Institute on Drug Abuse

Omeros Corporation, a Seattle-based clinical-stage biopharmaceutical company, announced that “the National Institute on Drug Abuse (NIDA) is providing support for the Company’s Addiction program. NIDA will fund substantially all of the costs of a Phase 2 clinical study to be … Continue reading

Posted in 43rd_district, Company_and_Client_News, Funding, Life_Sciences, Omeros, RTD, Seattle | Leave a comment

Washington Technology Center awards $394,910 to spur innovation and jobs

Four University of Washington researchers have been awarded state funding for partnerships with Washington companies developing innovative commercial technologies. SEATTLE — January 4, 2010 — Washington Technology Center has awarded a total of $394,910 in state funding to four University … Continue reading

Posted in Applied_Precision, Company_and_Client_News, Enertechnix, Funding, inVision_Technology, Omeros, RTD, WTC_News | Leave a comment

Omeros stock IPO closes lower in first two days of trading

Omeros Corporation, a Seattle-based biopharmaceutical company, saw its stock price close lower in its first two days of trading after the company’s initial public offering (IPO) on October 8, 2009. The company had priced its offering of 6.82 million shares … Continue reading

Posted in 43rd_district, Company_and_Client_News, Funding, Life_Sciences, Omeros, RTD, Seattle | Leave a comment